Protein tyrosine phosphatase SHP-1 modulates T cell responses by controlling Cbl-b degradation

Journal of Immunology

Volumn 195, Issue 9, 2015, Pages 4218-4227

  Xiao, Yun ^a,b,c   Qiao, Guilin ^d,f   Tang, Juan ^a,b   Tang, Rong ^a,b   Guo, Hui ^a   Warwar, Samantha ^a   Langdon, Wallace Y ^e   Tao, Lijian ^b   Zhang, Jian ^a,d  

^a OHIO STATE UNIVERSITY   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASITAS B LINEAGE LYMPHOMA PROTEIN; CD28 ANTIGEN; CELL PROTEIN; LIGASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; UNCLASSIFIED DRUG; CBL PROTEIN; CBLB PROTEIN, MOUSE; PROTEIN KINASE LCK; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IN VIVO STUDY; INHIBITION KINETICS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; TH2 CELL; UBIQUITINATION; ANIMAL; C57BL MOUSE; CHEMISTRY; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; T LYMPHOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD28; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; PROTO-ONCOGENE PROTEINS C-CBL; T-LYMPHOCYTES; TH2 CELLS; UBIQUITINATION;

EID: 84945152206     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501200     Document Type: Article

References (51)

1. Schwartz, R. H. 2003. T cell anergy. Annu. Rev. Immunol. 21: 305-334.
2. Acuto, O., and F. Michel. 2003. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat. Rev. Immunol. 3: 939-951.
3. Acuto, O., S. Mise-Omata, G. Mangino, and F. Michel. 2003. Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor. Immunol. Rev. 192: 21-31.
4. Li, D., I. Gál, C. Vermes, M. L. Alegre, A. S. Chong, L. Chen, Q. Shao, V. Adarichev, X. Xu, T. Koreny, et al. 2004. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J. Immunol. 173: 7135-7139.
5. Thien, C. B., and W. Y. Langdon. 2005. c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses. Biochem. J. 391: 153-166.
6. Zhang, J. 2004. Ubiquitin ligases in T cell activation and autoimmunity. Clin. Immunol. 111: 234-240.
7. Liu, Q., H. Zhou, W. Y. Langdon, and J. Zhang. 2014. E3 ubiquitin ligase Cbl-b in innate and adaptive immunity. Cell Cycle 13: 1875-1884.
8. Bachmaier, K., C. Krawczyk, I. Kozieradzki, Y. Y. Kong, T. Sasaki, A. Oliveira-dos-Santos, S. Mariathasan, D. Bouchard, A. Wakeham, A. Itie, et al. 2000. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403: 211-216.
9. Chiang, Y. J., H. K. Kole, K. Brown, M. Naramura, S. Fukuhara, R. J. Hu, I. K. Jang, J. S. Gutkind, E. Shevach, and H. Gu. 2000. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403: 216-220.
10. Zhang, J., T. Bárdos, D. Li, I. Gál, C. Vermes, J. Xu, K. Mikecz, A. Finnegan, S. Lipkowitz, and T. T. Glant. 2002. Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination. J. Immunol. 169: 2236-2240.
11. Qiao, G., Z. Li, L. Molinero, M. L. Alegre, H. Ying, Z. Sun, J. M. Penninger, and J. Zhang. 2008. T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. Mol. Cell. Biol. 28: 2470-2480.
12. Guo, H., G. Qiao, H. Ying, Z. Li, Y. Zhao, Y. Liang, L. Yang, S. Lipkowitz, J. M. Penninger, W. Y. Langdon, and J. Zhang. 2012. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity. Cell Reports 1: 472-482.
13. Jeon, M. S., A. Atfield, K. Venuprasad, C. Krawczyk, R. Sarao, C. Elly, C. Yang, S. Arya, K. Bachmaier, L. Su, et al. 2004. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21: 167-177.
14. Heissmeyer, V., F. Macián, S. H. Im, R. Varma, S. Feske, K. Venuprasad, H. Gu, Y. C. Liu, M. L. Dustin, and A. Rao. 2004. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat. Immunol. 5: 255-265.
15. Zhao, Y., H. Guo, G. Qiao, M. Zucker, W. Y. Langdon, and J. Zhang. 2015. E3 Ubiquitin Ligase Cbl-b Regulates Thymic-Derived CD4+CD25+ Regulatory T Cell Development by Targeting Foxp3 for Ubiquitination. J. Immunol. 194: 1639-1645.
16. Qiao, G., Y. Zhao, Z. Li, P. Q. Tang, W. Y. Langdon, T. Yang, and J. Zhang. 2013. T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells. J. Immunol. 191: 632-639.
17. Qiao, G., H. Ying, Y. Zhao, Y. Liang, H. Guo, H. Shen, Z. Li, J. Solway, E. Tao, Y. J. Chiang, et al. 2014. E3 ubiquitin ligase Cbl-b suppresses proallergic T cell development and allergic airway inflammation. Cell Reports 6: 709-723.
18. Magnifico, A., S. Ettenberg, C. Yang, J. Mariano, S. Tiwari, S. Fang, S. Lipkowitz, and A. M. Weissman. 2003. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J. Biol. Chem. 278: 43169-43177.
19. Yang, B., D. L. Gay, M. K. MacLeod, X. Cao, T. Hala, E. M. Sweezer, J. Kappler, P. Marrack, and P. M. Oliver. 2008. Nedd4 augments the adaptive immune response by promoting ubiquitin-mediated degradation of Cbl-b in activated T cells. Nat. Immunol. 9: 1356-1363.
20. Gruber, T., N. Hermann-Kleiter, R. Hinterleitner, F. Fresser, R. Schneider, G. Gastl, J. M. Penninger, and G. Baier. 2009. PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation. Sci. Signal. 2: ra30.
21. Kobashigawa, Y., A. Tomitaka, H. Kumeta, N. N. Noda, M. Yamaguchi, and F. Inagaki. 2011. Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b. Proc. Natl. Acad. Sci. USA 108: 20579-20584.
22. Ettenberg, S. A., A. Magnifico, M. Cuello, M. M. Nau, Y. R. Rubinstein, Y. Yarden, A. M. Weissman, and S. Lipkowitz. 2001. Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex. J. Biol. Chem. 276: 27677-27684.
23. Peschard, P., G. Kozlov, T. Lin, I. A. Mirza, A. M. Berghuis, S. Lipkowitz, M. Park, and K. Gehring. 2007. Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b. Mol. Cell 27: 474-485.
24. Johnson, D. J., L. I. Pao, S. Dhanji, K. Murakami, P. S. Ohashi, and B. G. Neel. 2013. Shp1 regulates T cell homeostasis by limiting IL-4 signals. J. Exp. Med. 210: 1419-1431.
25. Bairstow, S. F., K. Ling, and R. A. Anderson. 2005. Phosphatidylinositol phosphate kinase type Igamma directly associates with and regulates Shp-1 tyrosine phosphatase. J. Biol. Chem. 280: 23884-23891.
26. Salojin, K., J. Zhang, M. Cameron, B. Gill, G. Arreaza, A. Ochi, and T. L. Delovitch. 1997. Impaired plasma membrane targeting of Grb2-murine son of sevenless (mSOS) complex and differential activation of the Fyn-T cell receptor (TCR)-zeta-Cbl pathway mediate T cell hyporesponsiveness in autoimmune nonobese diabetic mice. J. Exp. Med. 186: 887-897.
27. Zhang, J., K. V. Salojin, J. X. Gao, M. J. Cameron, I. Bergerot, and T. L. Delovitch. 1999. p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells. J. Immunol. 162: 3819-3829.
28. Veselits, M., A. Tanaka, S. Lipkowitz, S. O'Neill, R. Sciammas, A. Finnegan, J. Zhang, and M. R. Clark. 2014. Recruitment of Cbl-b to B cell antigen receptor couples antigen recognition to Toll-like receptor 9 activation in late endosomes. PLoS One 9: e89792.
29. Ying, H., L. Yang, G. Qiao, Z. Li, L. Zhang, F. Yin, D. Xie, and J. Zhang. 2010. Cutting edge: CTLA-4-B7 interaction suppresses Th17 cell differentiation. J. Immunol. 185: 1375-1378.
30. Mostoslavsky, G., D. N. Kotton, A. J. Fabian, J. T. Gray, J. S. Lee, and R. C. Mulligan. 2005. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation. Mol. Ther. 11: 932-940.
31. Yang, Y., J. Weiner, Y. Liu, A. J. Smith, D. J. Huss, R. Winger, H. Peng, P. D. Cravens, M. K. Racke, and A. E. Lovett-Racke. 2009. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J. Exp. Med. 206: 1549-1564.
32. Nguyen, L. K., W. Kolch, and B. N. Kholodenko. 2013. When ubiquitination meets phosphorylation: a systems biology perspective of EGFR/MAPK signalling. Cell Commun. Signal. 11: 52.
33. Dou, H., L. Buetow, G. J. Sibbet, K. Cameron, and D. T. Huang. 2013. Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3. Nat. Struct. Mol. Biol. 20: 982-986.
34. Elly, C., S. Witte, Z. Zhang, O. Rosnet, S. Lipkowitz, A. Altman, and Y. C. Liu. 1999. Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation. Oncogene 18: 1147-1156.
35. Nguyen, T. V., Y. Ke, E. E. Zhang, and G. S. Feng. 2006. Conditional deletion of Shp2 tyrosine phosphatase in thymocytes suppresses both pre-TCR and TCR signals. J. Immunol. 177: 5990-5996.
36. Kuchroo, V. K., A. C. Anderson, H. Waldner, M. Munder, E. Bettelli, and L. B. Nicholson. 2002. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20: 101-123.
37. Davies, G. C., S. A. Ettenberg, A. O. Coats, M. Mussante, S. Ravichandran, J. Collins, M. M. Nau, and S. Lipkowitz. 2004. Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b. Oncogene 23: 7104-7115.
38. Lorenz, U. 2009. SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol. Rev. 228: 342-359.
39. Plas, D. R., C. B. Williams, G. J. Kersh, L. S. White, J. M. White, S. Paust, T. Ulyanova, P. M. Allen, and M. L. Thomas. 1999. Cutting edge: the tyrosine phosphatase SHP-1 regulates thymocyte positive selection. J. Immunol. 162: 5680-5684.
40. Zhang, J., A. K. Somani, D. Yuen, Y. Yang, P. E. Love, and K. A. Siminovitch. 1999. Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection. J. Immunol. 163: 3012-3021.
41. Carter, J. D., B. G. Neel, and U. Lorenz. 1999. The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds. Int. Immunol. 11: 1999-2014.
42. Plas, D. R., R. Johnson, J. T. Pingel, R. J. Matthews, M. Dalton, G. Roy, A. C. Chan, and M. L. Thomas. 1996. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling. Science 272: 1173-1176.
43. Croker, B. A., R. S. Lewis, J. J. Babon, J. D. Mintern, D. E. Jenne, D. Metcalf, J. G. Zhang, L. H. Cengia, J. A. O'Donnell, and A. W. Roberts. 2011. Neutrophils require SHP1 to regulate IL-1β production and prevent inflammatory skin disease. J. Immunol. 186: 1131-1139.
44. Lukens, J. R., P. Vogel, G. R. Johnson, M. A. Kelliher, Y. Iwakura, M. Lamkanfi, and T. D. Kanneganti. 2013. RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3. Nature 498: 224-227.
45. Pao, L. I., K. P. Lam, J. M. Henderson, J. L. Kutok, M. Alimzhanov, L. Nitschke, M. L. Thomas, B. G. Neel, and K. Rajewsky. 2007. B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 27: 35-48.
46. Kaneko, T., Y. Saito, T. Kotani, H. Okazawa, H. Iwamura, M. Sato-Hashimoto, Y. Kanazawa, S. Takahashi, K. Hiromura, S. Kusakari, et al. 2012. Dendritic cell-specific ablation of the protein tyrosine phosphatase Shp1 promotes Th1 cell differentiation and induces autoimmunity. J. Immunol. 188: 5397-5407.
47. Abram, C. L., G. L. Roberge, L. I. Pao, B. G. Neel, and C. A. Lowell. 2013. Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice. Immunity 38: 489-501.
48. Gronski, M. A., J. M. Boulter, D. Moskophidis, L. T. Nguyen, K. Holmberg, A. R. Elford, E. K. Deenick, H. O. Kim, J. M. Penninger, B. Odermatt, et al. 2004. TCR affinity and negative regulation limit autoimmunity. Nat. Med. 10: 1234-1239.
49. Hebeisen, M., L. Baitsch, D. Presotto, P. Baumgaertner, P. Romero, O. Michielin, D. E. Speiser, and N. Rufer. 2013. SHP-1 phosphatase activity counteracts increased T cell receptor affinity. J. Clin. Invest. 123: 1044-1056.
50. Stefanová, I., B. Hemmer, M. Vergelli, R. Martin, W. E. Biddison, and R. N. Germain. 2003. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat. Immunol. 4: 248-254.
51. Kemp, K. L., S. D. Levin, P. J. Bryce, and P. L. Stein. 2010. Lck mediates Th2 differentiation through effects on T-bet and GATA-3. J. Immunol. 184: 4178-4184.